🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
18,156
Companies
1,062
Drugs tracked
3,187

Quick answer

NovaPharmaNews tracks 18,156 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

1,425 results for “Elan” Clear

  1. Delandistrogene moxeparvovec-rokl

    Sarepta Therapeutics

    Duchenne Muscular Dystrophy

    phase 3 small molecule active

    1 trial

  2. Dexamethasone sodium phosphate

    Quince Therapeutics

    Ataxia Telangiectasia

    phase 3 small molecule completed

    2 trials

  3. Dexamethasone sodium phosphate for encapsulation into autoerythrocytes

    Quince Therapeutics

    Ataxia Telangiectasia (A-T)

    phase 3 small molecule active

    1 trial

  4. Discontinuation antipsychotic treatment

    Lxo Ireland Designated Activity Company

    Psychosis Nos/Other

    phase 3 small molecule active

    1 trial

  5. Dociparstat

    Jazz Pharmaceuticals Ireland Limited

    Acute Myeloid Leukemia

    phase 3 small molecule terminated

    1 trial

  6. Dociparstat sodium

    Jazz Pharmaceuticals Ireland Limited

    Coronavirus Disease 2019 (COVID-19)

    phase 3 small molecule terminated

    1 trial

  7. Dordaviprone (ONC201)

    Jazz Pharmaceuticals Ireland Limited

    H3 K27M

    phase 3 small molecule active

    1 trial

  8. Duloxetine

    Pacira Ireland Limited

    Knee Osteoarthritis

    phase 3 small molecule completed

    1 trial

  9. EIK1001

    Eikon Therapeutics

    Advanced Melanoma

    phase 3 small molecule active

    1 trial

  10. ELECTROLYTES , DURVALUMAB, VASOPRESSIN (ARGIPRESSIN) , PREDNISOLONE , INFLIXIMAB, MYCOPHENOLATE MOFETIL, PARACETAMOL , Tarlatamab, Tarlatamab, TOCILIZUMAB, ETOPOSIDE, DEXAMETHASONE, SILTUXIMAB, CARBOPLATIN, CISPLATIN

    Amgen Technology (Ireland) UC

    Extensive stage small cell lung cancer (ES-SCLC)

    phase 3 small molecule active

    1 trial

  11. ELIGARD 45 mg, poudre et solvant pour solution injectable

    Cancer Prevention Pharma (Ireland) Limited

    Prostatic adenocarnicoma with high risk of recurrence

    phase 3 small molecule active

    1 trial

  12. ELRANATAMAB

    Pfizer Ireland Pharmaceuticals Unlimited Company

    Multiple myeloma

    phase 3 small molecule active

    1 trial

  13. ELX/TEZ/IVA

    Vertex Pharmaceuticals (Ireland) Limited

    Cystic Fibrosis

    phase 3 small molecule active

    19 trials

  14. ENCORAFENIB, KEYTRUDA 25 mg/mL concentrate for solution for infusion, Binimetinib placebo, BINIMETINIB, Encorafenib Pacebo

    Pfizer Ireland Pharmaceuticals Unlimited Company

    Metastatic or unresectable locally advanced BRAF V600E/K mutation positive melanoma

    phase 3 small molecule active

    1 trial

  15. ETOPOSIDE - Usual

    Lxo Ireland Designated Activity Company

    Small Cell Lung Cancer

    phase 3 small molecule active

    1 trial

  16. ETOPOSIDE, ATEZOLIZUMAB, PF-08634404, CARBOPLATIN

    Pfizer Ireland Pharmaceuticals Unlimited Company

    Extensive-Stage Small Cell Lung Cancer

    phase 3 small molecule active

    1 trial

  17. ETOPOSIDE, PACLITAXEL, IFOSFAMIDE, CISPLATIN, CARBOPLATIN

    Cancer Prevention Pharma (Ireland) Limited

    Progressive or recurrent germ cell tumor (measurable or non-measurable)

    phase 3 small molecule active

    1 trial

  18. EVENITY 105 mg solution for injection in pre-filled syringe, EVENITY 105 mg solution for injection in pre-filled syringe, EVENITY 105 mg solution for injection in pre-filled pen, EVENITY 105 mg solution for injection in pre-filled pen

    Amgen Technology (Ireland) UC

    Osteogenesis Imperfecta

    phase 3 small molecule active

    1 trial

  19. EVEROLIMUS, EVEROLIMUS, PF-07248144, FULVESTRANT, EVEROLIMUS, EXEMESTANE, FULVESTRANT, PF-07248144

    Pfizer Ireland Pharmaceuticals Unlimited Company

    Hormone Receptor-Positive, HER2-Negative Advanced/Metastatic Breast Cancer

    phase 3 small molecule active

    1 trial

  20. EXPAREL

    Pacira Ireland Limited

    Total Ankle Arthroplasty

    phase 3 small molecule active

    1 trial

  21. EXPAREL 13.3Mg/mL Suspension for Injection

    Pacira Ireland Limited

    Bunion

    phase 3 small molecule terminated

    1 trial

  22. EXPAREL 266 mg

    Pacira Ireland Limited

    Posterolateral Thoracotomy

    phase 3 small molecule completed

    1 trial

  23. Erenumab, Placebo for AMG 334

    Amgen Technology (Ireland) UC

    Episodic Migraine

    phase 3 small molecule active

    1 trial

  24. EryDex System

    Quince Therapeutics

    Ataxia Telangiectasia

    phase 3 other terminated

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 18,156 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources